CoChat

α‐Synuclein up‐regulates expression of caveolin‐1 and down‐regulates extracellular signal‐regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease

Hashimoto, Makoto, Takenouchi, Takato, Rockenstein, Edward, Masliah, Eliezer · 2003 · Journal of Neurochemistry
Cited by 83

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

α‐Synuclein accumulation plays an important role in the pathogenesis of Lewy body disease (LBD) and Parkinson's disease (PD). Although the mechanisms are not yet clear, it is possible that dysregulation of the extracellular signal‐regulated kinase (ERK) might play a role. As caveolins form scaffolds onto which signaling molecules such as ERK can assemble, we propose that signaling alterations associated with α‐synuclein accumulation and neurodegeneration, might be mediated via caveolae. Therefore, the objective of the present study was to investigate the potential contribution of alterations in the caveolar system in mediating α‐synuclein effects on the ERK signaling pathway. For this, synuclein‐transfected B103 neuroblastoma cells were used as a model system. In this cell line, caveolin‐1 expression was up‐regulated, whereas, ERK was down‐regulated. ERK was weakly but consistently co‐immunoprecipitated with α‐synuclein but caveolin‐1 did not co‐immunoprecipitate with α‐synuclein. Moreover, treatment of α‐synuclein‐ overexpressing cells with caveolin‐1 antisense oligonucleotides resulted in stimulation of ERK activity, with amelioration of the neuritic alterations. Transduction of α‐synuclein‐overexpressing cells, with an adenoviral vector directing the expression of ERK, resulted in suppression of caveolin‐1 expression and re‐establishment of the normal patterns of neurite outgrowth. These results suggest that α‐synuclein may also interfere with ERK signaling by dysregulating caveolin‐1 expression. Thus, the caveolin‐1/ERK pathway could be a therapeutic target for the α‐synuclein‐related neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2003.01791.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 83

Metadata

Authors
Hashimoto, M., Takenouchi, T., Rockenstein, E., & Masliah, E.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2003-05-13
Volume
85
Issue
6
Pages
1468-1479
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1833512029
Cited by
83
References
6
FWCI
4.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: α‐Synuclein up‐regulates expression of caveolin‐1 and down‐regulates extracellular signal‐regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease. https://app.cochat.ai/papers/10.1046/j.1471-4159.2003.01791.x
The paper
Hashimoto, M., Takenouchi, T., Rockenstein, E., & Masliah, E. (2003). α‐Synuclein up‐regulates expression of caveolin‐1 and down‐regulates extracellular signal‐regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2003.01791.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.